LD-2 disclosure · 1st Quarter - Report
AMYLIN PHARMACEUTICALS
Expenses$340Kself-filed spend
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
Issues related to prevention, diagnosis and treatment of diabetes
Lobbyistsmr WILLIAM A FRANCO · CRAIG BURTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues relating to Medicare Part D rebates
Lobbyistsmr WILLIAM A FRANCO · CRAIG BURTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
FDA funding and agency effectiveness Potential Super Committee legislation affecting Medciare Part D and Medicaid rebates
Lobbyistsmr WILLIAM A FRANCO · CRAIG BURTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026